CLINICAL_TRIALS
trial_result
· 2013-11-15
Clinical Trial Update: Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma [Phase 2]
Summary
Phase II study of sagopilone (ZK-EPO) in metastatic melanoma completed; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2013-11-15